ID20165A - Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis - Google Patents

Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis

Info

Publication number
ID20165A
ID20165A IDW980073D ID980073D ID20165A ID 20165 A ID20165 A ID 20165A ID W980073 D IDW980073 D ID W980073D ID 980073 D ID980073 D ID 980073D ID 20165 A ID20165 A ID 20165A
Authority
ID
Indonesia
Prior art keywords
dimetoxicinamoil
aminobenzoat
restenosis
prevention
acid
Prior art date
Application number
IDW980073D
Other languages
English (en)
Inventor
Juichi Fukuyama
Keiji Miyazawa
Shuichiro Hamano
Arao Ujiie
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25101171&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID20165(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of ID20165A publication Critical patent/ID20165A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/606Salicylic acid; Derivatives thereof having amino groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
IDW980073D 1996-12-30 1997-12-19 Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis ID20165A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/774,418 US6019104A (en) 1996-12-30 1996-12-30 Method for the treatment or prevention of restenosis associated with coronary intervention

Publications (1)

Publication Number Publication Date
ID20165A true ID20165A (id) 1998-10-15

Family

ID=25101171

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW980073D ID20165A (id) 1996-12-30 1997-12-19 Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis

Country Status (19)

Country Link
US (1) US6019104A (id)
EP (1) EP0891185A2 (id)
KR (1) KR19990087396A (id)
CN (1) CN1220599A (id)
AR (1) AR009446A1 (id)
AU (1) AU7854198A (id)
BR (1) BR9707877A (id)
CA (1) CA2247306A1 (id)
CZ (1) CZ251198A3 (id)
EA (1) EA001931B1 (id)
HU (1) HUP9904029A3 (id)
ID (1) ID20165A (id)
IL (1) IL125660A0 (id)
NO (1) NO983947D0 (id)
NZ (1) NZ331338A (id)
PE (1) PE27399A1 (id)
TR (1) TR199801698T1 (id)
WO (1) WO1998029104A2 (id)
ZA (1) ZA9711719B (id)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4583597B2 (ja) * 1998-05-05 2010-11-17 ボストン サイエンティフィック リミテッド 末端が滑らかなステント
PL349926A1 (en) * 1999-02-03 2002-10-21 Smithkline Beecham Corp Method for the prevention or reduction of cardiovascular events associated with coronary intervention
JP2002536327A (ja) * 1999-02-03 2002-10-29 スミスクライン・ビーチャム・コーポレイション 冠状動脈インターベンションに伴う心臓血管事象の予防または軽減方法
AU2001243248A1 (en) * 2000-02-23 2001-09-03 Smith Kline Beecham Corporation Method for the prevention or reduction of vascular access dysfunction
US20050106230A1 (en) * 2003-11-17 2005-05-19 Young Janel E. Drug-enhanced adhesion prevention

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070484A (en) * 1973-01-18 1978-01-24 Kissei Pharmaceutical Co., Ltd. Antiallergic composition containing aromatic carboxylic amide derivatives and method of using the same
JPS5640710B2 (id) * 1973-01-18 1981-09-22
US4337270A (en) * 1980-05-21 1982-06-29 Hisamitsu Pharmaceutical Co., Inc. Novel anthranilic acid derivatives
JP2617407B2 (ja) * 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 血管内膜細胞過剰増殖疾患の予防および治療剤

Also Published As

Publication number Publication date
BR9707877A (pt) 1999-07-27
AU7854198A (en) 1998-07-31
CN1220599A (zh) 1999-06-23
EP0891185A2 (en) 1999-01-20
TR199801698T1 (xx) 1999-03-22
HUP9904029A3 (en) 2000-11-28
AR009446A1 (es) 2000-04-12
NO983947D0 (no) 1998-08-27
CZ251198A3 (cs) 1999-08-11
IL125660A0 (en) 1999-04-11
EA001931B1 (ru) 2001-10-22
KR19990087396A (ko) 1999-12-27
HUP9904029A2 (hu) 2000-05-28
WO1998029104A3 (en) 1998-10-01
US6019104A (en) 2000-02-01
CA2247306A1 (en) 1998-07-09
ZA9711719B (en) 1998-06-25
NZ331338A (en) 2000-12-22
PE27399A1 (es) 1999-03-31
WO1998029104A2 (en) 1998-07-09
EA199800781A1 (ru) 1999-12-29

Similar Documents

Publication Publication Date Title
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
FI962557A0 (fi) PLA2-inhibiittoreiden käyttö Alzheimerin taudin hoidossa
HK1005425A1 (en) Use of 2-(3,4-dimethoxycinnamoyl)-aminobenzoic acid for the manufacture of a medicament for the treatment of restenosis
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
DE69821667D1 (de) Kardioverter zur Behandlung von Vorhofflattern
ITTO950104A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
NO20011409L (no) Farmasöytiske midler for behandling av Parkinsonssykdom, ADHD og mikroadenomer
DE69824576D1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
NO20001869D0 (no) Fremgangsmõte for behandling av Alzheimerssykdom
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
IS1910B (is) Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi
BR9612074A (pt) Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas
ITTO950099A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
ID20165A (id) Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO982562D0 (no) Sammensetning for behandling av smerte
IT1296613B1 (it) Farmaco per la cura dell'ircismo contenente un adrenocorticosteroide.
DE69819503D1 (de) Verwendung von 7-apha-methyl-17-alpha-ethynyl-estrane derivaten zur behandlung von atherosclerose
DK8893D0 (da) Medicament for treatment or prevention of disease
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.
DE69822628D1 (de) Zur vorbeugung oder behandlung von östrogenabhängigen krankheiten nützliche pyrrolo[2.1.5-cd]indolizin-derivate
BR7301308U (pt) Disposição de identificação de tecidos.